CLASS II Device recall · Reported 24 Jan 2018 · FDA Enforcement Report

RayStation Product Usage: is a software system designed recalled

Raysearch Laboratories Ab is recalling RayStation Product Usage: is a software system designed for treatment, distributed nationwide in the US. The recall was initiated on 17 Jul 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes6.0.0.24 , 6.1.0.26 , 6.1.1.2 or 6.2.0.7
Quantity recalled117 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0380-2018
FDA event ID
78900
Recalling firm
Raysearch Laboratories Ab, Stockholm, N/A
Classification
Class II
Status
Terminated
Recall initiated
17 Jul 2017
FDA classified
16 Jan 2018
Reported
24 Jan 2018
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction
Device type
Medical Software

Timeline

17 Jul 2017Recall initiated by company
16 Jan 2018Classified by FDA+183 days
24 Jan 2018Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

For the proton QA preparation module in RayStation 6 (including SP1 and SP2), if the snout position or gap is modified in the QA module, the dose in the QA module may be computed for a different setup than what is used for QA measurements. This could result in an incorrect dosage being provided to a patient.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

RayStation Product Usage: is a software system designed for treatment planning and analysis of radiation therapy. The treatment plans provide treatment unit set-up parameters and estimates of dose distributions expected during the proposed treatment, and may be used to administer treatments after review and approval by the intended user.

Where it was distributed

US Nationwide Distribution - FL, WA, AZ, TN, MD, TX, FL, MI, Washington D.C.

Nationwide ArizonaFloridaMarylandMichiganTennesseeTexasWashington

Questions about this recall

Is RayStation Product Usage: is a software system designed for treatment recalled?

Yes. Raysearch Laboratories Ab recalled RayStation Product Usage: is a software system designed for treatment on 17 Jul 2017. The recall is Class II and its status is Terminated. Recall number Z-0380-2018.

Why was it recalled?

For the proton QA preparation module in RayStation 6 (including SP1 and SP2), if the snout position or gap is modified in the QA module, the dose in the QA module may be computed for a different setup than what is used for QA measurements. This could result in an incorrect dosage being provided to a patient.

Which lots are affected?

6.0.0.24 , 6.1.0.26 , 6.1.1.2 or 6.2.0.7

Where was it sold?

US Nationwide Distribution - FL, WA, AZ, TN, MD, TX, FL, MI, Washington D.C.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Raysearch Laboratories Ab

All 115

Other Medical Software recalls

All 903